Samjin Pharmaceuticals Co., Ltd. (005500.KS) KSC

18,940.00

-60(-0.32%)

Updated at September 08 12:42PM

Currency In KRW

Samjin Pharmaceuticals Co., Ltd.

Address

121 Wausan Ro

Seoul, 04054

Korea, Republic of

Phone

82 2 3140 0700

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

586

First IPO Date

September 29, 2005

Key Executives

NameTitlePayYear Born
Ji-hyeon ChoiChief Executive Officer & Director0N/A

Description

Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company's products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage products for the treatment of cancer; SPJ1604 and SPJ003 clinical phase products for the treatment of cancer and diabetes; and SJP1901, SJP1902, SJP1801, and SJP006 biological testing stage products for the treatment of cancer, fibrosis, cancer immunotherapy, alzheimer's disease, Parkinson's disease, and anti-viral disease. The company was founded in 1968 and is headquartered in Seoul, South Korea.